Liposomal Hemorrhoid Master
NDC Package 63742-022-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Liposomal Hemorrhoid Master is adults: When practical, cleanse the affected area with mild soap and warm water and rinse thoroughly. Marketed by Clinical Resolution Laboratory, Inc., this product is identified by NDC 63742-022 and is authorized under FDA application M015.

Identification & Billing

NDC Package Code
63742-022-01
Package Description
1 TUBE in 1 CARTON / 45 g in 1 TUBE
Product Code
63742-022
11-Digit Billing Format
63742002201
RxNorm Crosswalk
  • RxCUI: 2672354 - lidocaine 5 % / phenylephrine HCl 0.25 % Rectal Ointment
  • RxCUI: 2672354 - lidocaine 0.05 MG/MG / phenylephrine hydrochloride 0.0025 MG/MG Rectal Ointment
  • RxCUI: 2672354 - lidocaine 5 % / phenylephrine hydrochloride 0.25 % Rectal Ointment

Clinical Specifications

Proprietary Name
Liposomal Hemorrhoid Master
Dosage Form
-
Usage Information
Adults: When practical, cleanse the affected area with mild soap and warm water and rinse thoroughly. Gently dry by patting or blotting with toilet tissue or a soft cloth before application of this product. Children under 12 years of age: consult a doctor.For External use: Apply externally to the affected area up to 4 times daily. For Intrarectal use: Attach applicator to tube. Lubricate applicator well, then gently insert applicator into the rectum. Apply to the affected area up to 4 times daily.

Regulatory & Marketing

Labeler Name
Clinical Resolution Laboratory, Inc.
FDA Application #
M015
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
01-01-2024
Listing Expiration
12-31-2024
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 63742-022-01 identifies a specific commercial package of 1 tube in 1 carton / 45 g in 1 tube of Liposomal Hemorrhoid Master, labeled by Clinical Resolution Laboratory, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Clinical Resolution Laboratory, Inc. on January 01, 2024. The current certification is valid through December 31, 2024.

How is this Clinical Resolution Laboratory, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 63742002201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
63742-022-01
11-Digit CMS (5-4-2)
63742-0022-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.